Category: Articles

Tackling misconceptions: Hepatitis C treatment for people who use drugs

With the advent of treatments called direct-acting antivirals (DAAs), a huge number of people across Canada have been successfully cured of hepatitis C. However, efforts to cure some of the most affected communities continue to be hindered by incorrect or outdated information. For example, many successes in curing hepatitis C have been achieved through the determination of people who use drugs, and yet they still encounter access barriers due to discrimination and problematic misconceptions around treatment eligibility. These gaps in knowledge can be addressed by raising awareness about hepatitis C treatment and organizations across Canada have been working to clarify...

Read more

Busting common myths about hepatitis C treatment in Canada

Highly effective medications that can cure hepatitis C infection, called direct-acting antivirals (DAAs), have been approved for use in Canada for people over the age of 18 since 2014. These medications are well-tolerated, nearly 100% effective, and have treatment durations of just eight or 12 weeks. DAAs have simplified hepatitis C treatment considerably, allowing treatments to be prescribed by primary care providers, such as nurse practitioners and family doctors. Now that the treatment itself is so simple, getting coverage for reimbursement of DAAs is the most complicated and challenging aspect of treating hepatitis C infection in Canada. Almost 90% of...

Read more

A conversation between Dr. Theresa Tam and Jade Elektra

Undetectable = Untransmittable (U=U) refers to the scientific consensus that HIV cannot be sexually transmitted when a person living with HIV consistently takes antiretroviral therapy (ART) and the amount of HIV in their blood remains very low—so low that it cannot be detected by many standard HIV tests. While the U=U message empowers people living with HIV and reduces stigma associated with the virus, it is only effective if individuals living with HIV are able to continuously take their medication. Some people in Canada, such as African, Caribbean and Black communities, Indigenous people, gay, bisexual, and other men who have...

Read more

Insights from the Engage Study: HPV vaccine effectiveness and uptake among gay, bisexual and other men who have sex with men

Human papillomavirus (HPV) is a very common virus that is most easily passed during sexual contact. The body clears most HPV infections on its own, however some become persistent. There are many different types of HPV. Certain types can cause cancer, including anal, cervical and oral cancers. Some types cause anal and genital warts. HPV cannot be cured by medication, but there are vaccines that can prevent a person from getting some types of HPV. All HPV vaccines protect against the two types that cause most cases of anal and cervical cancer (types 16 and 18), and some vaccines protect...

Read more

Doxy-PEP for syphilis prevention: What is it, does it work and how can we overcome barriers to access?

For years, gay, bisexual, trans, Two-Spirit and queer (GBT2Q) communities have been experiencing unacceptably high rates of syphilis with limited action taken by others outside the work of community-based sexual health organizations. However, provincial and federal responses have been stoked due to an increase in heterosexual transmission and a rise in cases of babies born with syphilis, also known as congenital syphilis. When acquired by a fetus during pregnancy, syphilis can result in miscarriage, stillbirth or permanent disability of the newborn. Consequently, efforts to leverage innovative syphilis interventions have accelerated, alongside interest in new prevention options for GBT2Q men. One...

Read more

AIDS Action Now! is disbanding

After 35 years of fierce activism, AIDS Action Now!, the HIV treatment activist group, is shutting down. AIDS Action Now! was formed in Toronto in 1988 as a community-based response to the lack of institutional leadership regarding treatment and healthcare for people living with HIV/AIDS. Its strategy was to combine confrontational public demonstrations with strategic documents and “behind the scenes” meetings with government and institutional leaders. These meetings pushed decision-makers to respond more forcefully to HIV healthcare at a time when it was highly stigmatized and few treatment options were available. Guided by a steering committee composed mostly of people...

Read more